Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice
Katerina T. Xenaki, B. Dorresteijn, J. Muns, K. Adamzek, S. Doulkeridou, H. Houthoff, S. Oliveira, P. M. P. van Bergen en Henegouwen
Theranostics